Federal regulators have sent a much-hyped Novo Nordisc (NVO) drug back to the drawing board...which is great for competitors like Sanofi (SNY) More
-
Sponsored By:
-
Sponsored By:
-
Sponsored By:
GMCR
10 Hottest Stocks for Options Traders
The CBOE saw a sharp drop in volume from the second most-traded stock to the third most-traded stock. More
Apple’s Rescue Too Little Too Late — Thursday’s IP Market Recap
Downbeat jobs and productivity news coupled with a string of crummy earnings reports to send the broader markets into the red Thursday. More
Shrinking GDP Sinks Stocks — Wednesday’s IP Market Recap
Markets reacted broadly on the down side Wednesday as a Commerce Department report showed surprising weakness in GDP growth and the Fed left rates unchanged. More
S&P 500? More Like 1,500! — Thursday’s IP Market Recap
The S&P 500 grazed the 1,500 mark Thursday for the first time since 2007, but Apple shareholders weren't among those celebrating. More
Dell Dealing, Apple Reeling — Monday’s IP Market Recap
Dell surged Monday on news of a possible private equity deal, while Apple tumbled on reportedly low demand for iPhone 5s. More
Flu Season: Where Investors Can Find Relief
This year's flu looks particularly troublesome, but that's good new for the many companies that benefit from flu sufferers' ills. Here's a look at some of them. More
